Update from Material Subsidiary on its proposed investment
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures' material subsidiary, Time Medical International Ventures (India) Pvt Ltd, has approved an investment of USD 12.5 million to acquire a 15% stake in Nanomedic Technologies and Solutions Pte Limited, a Singapore-based bio-medical therapeutics company. The target specialises in developing and manufacturing the Spincare System, an advanced wound treatment platform. The investment is entirely in cash, not a related party transaction, and requires no government or regulatory approvals. The target was only incorporated in FY 2024-25 and currently has no turnover, making this a pre-revenue bet on innovative wound care technology. The acquisition is aimed at diversifying and expanding the subsidiary's business footprint.
This signals a strategic diversification into biomedical and wound care technology, but the target has no revenue yet, so the deal carries early-stage execution risk. For shareholders, the $12.5 million size is meaningful but not transformative, and near-term impact on the listed entity's financials is likely limited.